Repligen Corp
RGEN: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|>H | LOCK|&m&h | LOCK|?r^wv!f |
Repligen Earnings: Double-Digit Top-Line Growth; Full-Year Guidance Raised
Repligen reported second-quarter year-on-year revenue growth of 15% and an adjusted operating margin of 12%, which is 80 percentage points worse than the same period last year. It significantly raised its full-year guidance for revenue growth to 14.5% at the midpoint, or 3 percentage points higher.
